Platinum Sensitive Relapsed Ovarian Cancer
Platinum Sensitive Relapsed Ovarian Cancer is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Also known as
- relapsed platinum-sensitive Ovarian cancer · relapsed Platinum Sensitive Ovarian Cancer · Platinum-sensitive Relapsed Ovarian Cancer
- Indicated drugs
What you can answer from here — as of November 22, 2026
Which approved drugs for Platinum Sensitive Relapsed Ovarian Cancer share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account